Related Experiment Videos
A psychological perspective for double-blind trials
Abstract:
Blind breaking is likely to occur in a long-term clinical trial involving subjects at risk. Double-blind conditions require subjects to live with ambiguity regarding their health status. It is unrealistic to expect them to tolerate this ambiguity over an extended period of time. A logical step for a subject is to break the blind and surreptitiously seek the best medical care available. Moreover, the staff assigned to monitor protocol adherence may further contribute to blind breaking because of ambiguity regarding their proper clinical role. Several steps are recommended to manage blind breaking within a trial, including improving the quality of medical care, more rigorous screening procedures, and maintaining a clinical environment that promotes accurate disclosure of blind breaking.
Insights
Blind breaking in clinical trials is common due to prolonged ambiguity. Strategies to manage this include better medical care, screening, and fostering an environment for open disclosure.
Area of Science:
- Clinical Trials
- Medical Ethics
Background:
- Long-term clinical trials pose challenges for maintaining participant blinding.
- Participants at risk may experience significant ambiguity regarding their health status.
Purpose of the Study:
- To identify factors contributing to blind breaking in clinical trials.
- To recommend strategies for managing blind breaking effectively.
Main Methods:
- Analysis of factors influencing participant and staff behavior in blinded trials.
- Review of clinical trial protocols and ethical considerations.
Main Results:
- Participant ambiguity and staff role confusion are key drivers of blind breaking.
- The desire for optimal medical care can lead participants to breach blinding.
Conclusions:
- Improving medical care quality and participant screening can reduce blind breaking.
- Creating an open clinical environment is crucial for accurate disclosure and trial integrity.